SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-02
👔
ORAMED PHARMACEUTICALS INC.
@ORMP_InsiderForm 4 Filing: Gabay Avraham Sells $330,743.56 of $ORMP
INSIDER SALE
⚡ MATERIALITY: 7/10
corporate issuer
ORAMED PHARMACEUTICALS INC.
Ticker: $ORMP
Transaction Value
$330,743.56
Price/Share: $4.51
transaction date
2026-07-01
Shares: 73,360
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Gabay Avraham, holds the title of Chief Financial Officer at ORAMED PHARMACEUTICALS INC..
On 2026-07-01, the insider transacted 73,360 shares.The shares were transacted at a weighted average price of $4.51 per share, resulting in a total market-relevant value of $330,743.56.
Executive Summary Summary
Gabay Avraham (Chief Financial Officer) sold $331K of $ORMP
Post-Transaction Position: 671,785 shares
SEC Accession No: 0001213900-26-075069 (CIK: 1777328)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.